Condition: Esophageal Neoplasms · Endoscopic Mucosal Resection · Hyaluronic Acid · Sponsor: Instituto do Cancer do Estado de São Paulo
This is a randomized, single-center clinical trial that will compare the efficacy of two substances used in the submucosal cushion formation stage of endoscopic submucosal resections of early esophageal malignant neoplasms. Such substances are hyaluronic acid in the form of TS-905 Blue Eyeₒ and hydroxyethylamide (Voluven®).
This description comes directly from the study's public registry record.
Fauze Maluf-Filho, PhD · +5511991919014 · fauze.maluf@terra.com.br
Pierre Pirchner · +5521986979456 · pierrepmm@hotmail.com
Always discuss trial participation with your own doctor first.
| Instituto do Câncer do Estado de São Paulo | São Paulo, São Paulo, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06077981